Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
Filed Mar 14, 2013 · 10-K · 73 days after period end · 0001157523-13-001397
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $22.61M | $18.44M | — |
| Net Income | $4.46M | $2.88M | — |
| EPS Diluted | $0.31 | $0.21 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 14, 2013 · 73 d after period end
